本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

NovaBay Pharmaceuticals Inc

0.6101
-0.0081-1.31%
盤後0.6000-0.0101-1.66%16:15 EDT
成交量:7,696.00
成交額:4,699.63
市值:354.85萬
市盈率:1.08
高:0.6192
開:0.6048
低:0.6000
收:0.6182
資料載入中...
2024/07/23

SEC問詢函

Form CORRESP - Correspondence
2024/07/23

SEC問詢函

Form CORRESP - Correspondence
2024/07/13

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/07/11

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/07/11

重要事件披露

Form 8-K - Current report
2024/07/10

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/07/10

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/06/26

SEC問詢函

Form CORRESP - Correspondence
2024/06/21

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/06/21

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/20

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/06/14

重要事件披露

Form 8-K - Current report
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/31

重要事件披露

Form 8-K - Current report
2024/05/31

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/05/29

重要事件披露

Form 8-K - Current report
2024/05/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/22

重要事件披露

Form 8-K - Current report
2024/04/19

重要事件披露

Form 8-K - Current report
2024/03/29

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]